NEW YORK–(BUSINESS WIRE)– Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the 42nd
Annual Deutsche Bank Health Care Conference on Thursday, May 4, 2017, in
Boston. Charles
Bancroft executive vice president, head of Global Business
Operations, will answer questions about the company at 11:20 a.m. EDT.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.
Image may be NSFW.
Clik here to view.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170427005027/en/
Contacts
Bristol-Myers Squibb Company
Media:
Ken Dominski,
609-252-5251
ken.dominski@bms.com
or
Investors:
Tim
Power 609-252-7509
timothy.power@bms.com
or
Bill
Szablewski, 609-252-5894
william.szablewski@bms.com
Source: Bristol-Myers Squibb Company
Cet article Bristol-Myers Squibb to Take Part in Deutsche Bank Annual Health Care
Conference est apparu en premier sur EEI-BIOTECHFINANCES.